We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS

Tibotec

Community Affairs Manager:

Lew Sibert, V.P., Global Professional Affairs

Email: lsibert@its.jnj.com

Telephone Number: 813-390-1333

Arnold Doyle, Professional Affairs

Telephone Number: 201-234-9093

Approved Drugs:

1) Prezista (darunavir, formerly known as TMC114), Protease Inhibitor (PI)

2) Intelence (etravirine, formerly known as TMC125), Non-nucleoside reverse transcriptase inhibitor (NNRTI)

Drugs in Pre-approval Status:

1) TMC278 (rilpivirine), Non-nucleoside reverse transcriptase inhibitor, currently in Phase III for HIV

2) Two products for hepatitis C, one in conjunction with Medivir (TMC435), one in conjunction with Vertex (VX-950)